Artiva

Artiva, fresh from Merck pact, raises $120M for NK therapy R&D
Fierce Biotech
Mon, 03/1/21 - 10:39 am
Artiva
natural killer cell therapy
Merck
R&D
Natural killer biotech Artiva launches with $78M, industry veterans
Fierce Biotech
Fri, 06/26/20 - 09:50 am
immuno-oncology
natural killer cell therapy
Artiva